Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Idec receives expedited FDA review for potential multiple sclerosis relapse drug
Biogen Idec receives expedited FDA review for potential multiple sclerosis relapse drug
Biogen Idec receives expedited FDA review for potential multiple sclerosis relapse drug
Submitted by
admin
on July 8, 2009 - 10:15am
Source:
Yahoo/AP
News Tags:
Biogen Idec
MS
multiple sclerosis
FDA
Headline:
Biogen Idec receives expedited FDA review for potential multiple sclerosis relapse drug
Do Not Allow Advertisers to Use My Personal information
